Custom crystal commemorating the approval by the FDA of Ingrezza, the first drug approved for the treatment of the neurological condition tardive dyskinesia. (8ALJ380)
Custom crystal commemorating the approval by the FDA of Ingrezza, the first drug approved for the treatment of the neurological condition tardive dyskinesia. (8ALJ380)
"*" indicates required fields
There's a real irony at work when it comes to years-of-service award ideas and designs. These are, after all, awards recognizing loyalty and commitment---and over a sustained period of time. But "time" is something most years-of-service awards...
Ordering a sample deal toy is a wise move, but a pointless one if you're not attuned to some potential issues and problems. The process of ordering sample deal toys has changed considerably in recent years. As a result of the pandemic, and of the...
With the run-up to Super Bowl LV on Sunday, February 7th, we thought we'd update a post focusing on a Lucite embedment that resulted from an earlier Super Bowl game. No, the Philadelphia Eagles won't be going to the game this year; but the Kansas...